Joshua Xu Data-verified

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

High Impact

Researcher

Last publication 2025 Last refreshed 2026-05-16

faculty

31 h-index 198 pubs 5,923 cited

Biography and Research Information

OverviewAI-generated summary

Joshua Xu's research focuses on the development and application of high-throughput sequencing and multi-omics data integration for toxicological assessment and precision medicine. His work investigates methods to improve the accuracy and reliability of genomic analyses, particularly in the context of clinical diagnosis and predictive toxicology. This includes developing and validating reference materials and ratio-based quantitative profiling techniques to correct for batch effects and enhance the quality of transcriptomic and epigenomic data.

Dr. Xu has published extensively on topics related to evaluating analytical validity of DNA sequencing assays, resolving structural variants, and integrating multi-omics data. His research also explores the trade-offs between predictivity and explainability in machine learning models used for predictive toxicology, with applications to large-scale data sets. He collaborates with researchers at the National Center for Toxicological Research and the University of Arkansas for Medical Sciences, contributing to a network focused on advancing toxicological research and its applications in human health.

With an h-index of 31 and nearly 200 publications, Dr. Xu is recognized as a highly cited researcher. His work directly supports the goals of regulatory agencies like the U.S. Food and Drug Administration by providing robust methodologies for assessing the performance of genomic assays and for understanding the complex interactions of environmental factors and biological systems.

Metrics

  • h-index: 31
  • Publications: 198
  • Citations: 5,923

Selected Publications

  • Federated learning: a privacy-preserving approach to data-centric regulatory cooperation (2025)
    2 citations DOI OpenAlex
  • Leveraging FDA Labeling Documents and Large Language Model to Enhance Annotation, Profiling, and Classification of Drug Adverse Events with AskFDALabel (2025)
    9 citations DOI OpenAlex
  • Enhancing pharmacogenomic data accessibility and drug safety with large language models: a case study with Llama3.1 (2024)
    4 citations DOI OpenAlex
  • Targeted DNA-seq and RNA-seq of Reference Samples with Short-read and Long-read Sequencing (2024)
    6 citations DOI OpenAlex
  • Description and Validation of a Novel AI Tool, LabelComp, for the Identification of Adverse Event Changes in FDA Labeling (2024)
    5 citations DOI OpenAlex
  • Assessing the performance of large language models in literature screening for pharmacovigilance: a comparative study (2024)
    8 citations DOI OpenAlex
  • Automatic text classification of drug-induced liver injury using document-term matrix and XGBoost (2024)
    4 citations DOI OpenAlex
  • PERform: assessing model performance with predictivity and explainability readiness formula (2024)
    2 citations DOI OpenAlex
  • Towards accurate indel calling for oncopanel sequencing through an international pipeline competition at precisionFDA (2024)
    3 citations DOI OpenAlex
  • A framework enabling LLMs into regulatory environment for transparency and trustworthiness and its application to drug labeling document (2024)
    11 citations DOI OpenAlex
  • Extend the benchmarking indel set by manual review using the individual cell line sequencing data from the Sequencing Quality Control 2 (SEQC2) project (2024)
    5 citations DOI OpenAlex
  • RxBERT: Enhancing drug labeling text mining and analysis with AI language modeling (2023)
    12 citations DOI OpenAlex
  • Measurement and Mitigation of Bias in Artificial Intelligence: A Narrative Literature Review for Regulatory Science (2023)
    26 citations DOI OpenAlex
  • Quartet DNA reference materials and datasets for comprehensively evaluating germline variant calling performance (2023)
    28 citations DOI OpenAlex
  • Author Correction: Quartet RNA reference materials improve the quality of transcriptomic data through ratio-based profiling (2023)
    13 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

395 Collaborators 160 Institutions 19 Countries

Top Collaborators

View profile →
View profile →

Similar Researchers

Based on overlapping research topics